The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Sebastian Schneeweiss

Division of Pharmacoepidemiology and Pharmacoeconomics

Department of Medicine

Brigham and Women's Hospital

Boston

USA

[email]@*.harvard.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, USA. 2001 - 2012
  • Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, USA. 2004 - 2010
  • Department of Epidemiology, Harvard School of Public Health, Boston, USA. 2001 - 2002
  • Department of Medical Informatics, Biometry and Epidemiology, Pharmacoepidemiology Research Group, Ludwig-Maximilians-University, Germany. 2001 - 2002
  • Harvard Medical School, USA. 2000

References

  1. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. Schneeweiss, S., Rassen, J.A., Glynn, R.J., Myers, J., Daniel, G.W., Singer, J., Solomon, D.H., Kim, S., Rothman, K.J., Liu, J., Avorn, J. BMC. Med. Res. Methodol (2012) [Pubmed]
  2. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Schneeweiss, S., Patrick, A.R., Solomon, D.H., Mehta, J., Dormuth, C., Miller, M., Lee, J.C., Wang, P.S. Arch. Gen. Psychiatry (2010) [Pubmed]
  3. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Schneeweiss, S., Patrick, A.R., Solomon, D.H., Dormuth, C.R., Miller, M., Mehta, J., Lee, J.C., Wang, P.S. Pediatrics (2010) [Pubmed]
  4. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Schneeweiss, S. Pharmacoepidemiol. Drug. Saf (2010) [Pubmed]
  5. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Schneeweiss, S., Glynn, R.J., Avorn, J., Mamdani, M., Mogun, H., Solomon, D.H. Pharmacoepidemiol. Drug. Saf (2009) [Pubmed]
  6. Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data. Schneeweiss, S., Setoguchi, S., Brookhart, M.A., Kaci, L., Wang, P.S. CNS. Drugs (2009) [Pubmed]
  7. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Schneeweiss, S., Korzenik, J., Solomon, D.H., Canning, C., Lee, J., Bressler, B. Aliment. Pharmacol. Ther. (2009) [Pubmed]
  8. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H., Brookhart, M.A. Epidemiology (2009) [Pubmed]
  9. Aprotinin during coronary-artery bypass grafting and risk of death. Schneeweiss, S., Seeger, J.D., Landon, J., Walker, A.M. N. Engl. J. Med. (2008) [Pubmed]
  10. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Schneeweiss, S., Setoguchi, S., Weinblatt, M.E., Katz, J.N., Avorn, J., Sax, P.E., Levin, R., Solomon, D.H. Arthritis Rheum. (2007) [Pubmed]
  11. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss, S., Patrick, A.R., Maclure, M., Dormuth, C.R., Glynn, R.J. Circulation (2007) [Pubmed]
  12. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Schneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., Wang, P.S. CMAJ (2007) [Pubmed]
  13. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Schneeweiss, S., Patrick, A.R., Stürmer, T., Brookhart, M.A., Avorn, J., Maclure, M., Rothman, K.J., Glynn, R.J. Med. Care (2007) [Pubmed]
  14. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Schneeweiss, S., Patrick, A.R., Maclure, M., Dormuth, C.R., Glynn, R.J. Am. J. Manag. Care (2007) [Pubmed]
  15. Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., Solomon, D.H. J. Clin. Epidemiol (2007) [Pubmed]
  16. Developments in post-marketing comparative effectiveness research. Schneeweiss, S. Clin. Pharmacol. Ther. (2007) [Pubmed]
  17. Understanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases". Schneeweiss, S. J. Clin. Epidemiol (2007) [Pubmed]
  18. Methods in pharmacoepidemiology: time-varying drug effects revisited. Schneeweiss, S. Pharmacoepidemiol. Drug. Saf (2006) [Pubmed]
  19. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Schneeweiss, S. Pharmacoepidemiol. Drug. Saf (2006) [Pubmed]
  20. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Schneeweiss, S., Maclure, M., Dormuth, C.R., Glynn, R.J., Canning, C., Avorn, J. Clin. Pharmacol. Ther. (2006) [Pubmed]
  21. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Schneeweiss, S., Solomon, D.H., Wang, P.S., Rassen, J., Brookhart, M.A. Arthritis Rheum. (2006) [Pubmed]
  22. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Schneeweiss, S., Glynn, R.J., Tsai, E.H., Avorn, J., Solomon, D.H. Epidemiology (2005) [Pubmed]
  23. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. Schneeweiss, S., Glynn, R.J., Avorn, J., Solomon, D.H. J. Clin. Epidemiol (2005) [Pubmed]
  24. A review of uses of health care utilization databases for epidemiologic research on therapeutics. Schneeweiss, S., Avorn, J. J. Clin. Epidemiol (2005) [Pubmed]
  25. Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. Schneeweiss, S., Wang, P.S. J. Am. Geriatr. Soc (2005) [Pubmed]
  26. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. Schneeweiss, S., Maclure, M., Carleton, B., Glynn, R.J., Avorn, J. BMJ (2004) [Pubmed]
  27. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. Schneeweiss, S., Wang, P.S., Avorn, J., Maclure, M., Levin, R., Glynn, R.J. J. Gen. Intern. Med (2004) [Pubmed]
  28. Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents. Schneeweiss, S., Dormuth, C., Grootendorst, P., Soumerai, S.B., Maclure, M. Med. Care (2004) [Pubmed]
  29. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. Schneeweiss, S., Wang, P.S. J. Clin. Psychopharmacol (2004) [Pubmed]
  30. Costs of measuring outcomes of acute hospital care in a longitudinal outcomes measurement system. Schneeweiss, S., Manstetten, A., Wildner, M., Sangha, O., Liebetrau, M., Paeger, A. Am. J. Med. Qual (2003) [Pubmed]
  31. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Schneeweiss, S., Soumerai, S.B., Maclure, M., Dormuth, C., Walker, A.M., Glynn, R.J. Clin. Pharmacol. Ther. (2003) [Pubmed]
  32. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. Schneeweiss, S., Walker, A.M., Glynn, R.J., Maclure, M., Dormuth, C., Soumerai, S.B. N. Engl. J. Med. (2002) [Pubmed]
  33. Prescription duration after drug copay changes in older people: methodological aspects. Schneeweiss, S., Maclure, M., Soumerai, S.B. J. Am. Geriatr. Soc (2002) [Pubmed]
  34. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. Schneeweiss, S., Soumerai, S.B., Glynn, R.J., Maclure, M., Dormuth, C., Walker, A.M. CMAJ (2002) [Pubmed]
  35. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Schneeweiss, S., Hasford, J., Göttler, M., Hoffmann, A., Riethling, A.K., Avorn, J. Eur. J. Clin. Pharmacol. (2002) [Pubmed]
  36. Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. Schneeweiss, S., Maclure, M., Soumerai, S.B., Walker, A.M., Glynn, R.J. J. Clin. Epidemiol (2002) [Pubmed]
  37. Pharmaceutical cost containment with reference-based pricing: time for refinements. Schneeweiss, S., Maclure, M., Dormuth, C., Avorn, J. CMAJ (2002) [Pubmed]
  38. On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective. Schneeweiss, S., Maclure, M., Walker, A.M., Grootendorst, P., Soumerai, S.B. Health. Policy (2001) [Pubmed]
  39. First results from an intensified monitoring system to estimate drug related hospital admissions. Schneeweiss, S., Göttler, M., Hasford, J., Swoboda, W., Hippius, M., Hoffmann, A.K., Riethling, A.K., Krappweis, J. Br. J. Clin. Pharmacol (2001) [Pubmed]
  40. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Schneeweiss, S., Seeger, J.D., Maclure, M., Wang, P.S., Avorn, J., Glynn, R.J. Am. J. Epidemiol. (2001) [Pubmed]
  41. Sensitivity analysis of the diagnostic value of endoscopies in cross-sectional studies in the absence of a gold standard. Schneeweiss, S. Int. J. Technol. Assess. Health. Care (2000) [Pubmed]
 
WikiGenes - Universities